HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hori, J. Articles by Streilein, J. W. Search for Related Content PubMed PubMed Citation Articles by Hori, J. Articles by Streilein, J. W.

Immune Privilege and Immunogenicity Reside among Different Layers of the Mouse Cornea

From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

PURPOSE. To determine the extent to which each layer of the mouse cornea displays alloimmunogenicity or immune privilege.

METHODS. Intact corneas or individual or combined layers of corneas from normal or cauterized eyes of BALB/c, C57BL/6, and CD95L-deficient B6-gld mice were grafted beneath the kidney capsule of normal BALB/c, B10.D2, BALB.B mice or of BALB/c mice presensitized to donor antigens. Graft fate was assessed clinically and histologically and acquisition of donor-specific delayed hypersensitivity (DH) was assessed at selected intervals after grafting.

RESULTS. Full-thickness allogeneic corneas induced vigorous DH and were rejected acutely. Similar results were obtained with allografts of corneal epithelium alone (if supported by syngeneic viable stroma), allografts of epithelium from cauterized corneas (containing Langerhans’ cells), and stromal allografts deprived of endothelium. Grafts comprised of stroma plus endothelium (without epithelium) were not rejected, nor did they induce DH unless the graft had no CD95L expression. If stroma–endothelium grafts had no CD95L expression, DH directed against major histocompatibility complex (MHC), but not minor histocompatibility, alloantigens was induced. Moreover, CD95L expressed on stroma–endothelium grafts protected endothelial cells, but not stromal cells, from rejection in presensitized recipients.

CONCLUSIONS. When grafted to a heterotopic site, the alloimmunogenicity of the normal cornea resides within its epithelial and stromal layers, whereas immune privilege arises from the endothelium. In normal mice, CD95L-expressing endothelium can inhibit the stroma from inducing immunity directed at MHC alloantigens, but in presensitized mice the endothelium can protect itself only from immune rejection.

This article has been cited by other articles:

				T. Hayashi, S. Yamagami, K. Tanaka, S. Yokoo, T. Usui, S. Amano, and N. Mizuki Immunologic Mechanisms of Corneal Allografts Reconstituted from Cultured Allogeneic Endothelial Cells in an Immune-Privileged Site Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3151 - 3158. [Abstract] [Full Text] [PDF]

				J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146. [Abstract] [Full Text] [PDF]

				J. Hori, M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts J. Immunol., November 1, 2006; 177(9): 5928 - 5935. [Abstract] [Full Text] [PDF]

				J Plskova, L Kuffova, M Filipec, V Holan, and J V Forrester Quantitative evaluation of the corneal endothelium in the mouse after grafting Br. J. Ophthalmol., September 1, 2004; 88(9): 1209 - 1216. [Abstract] [Full Text] [PDF]

				H. Osawa, K. Maruyama, and J. W. Streilein CD95 Ligand Expression on Corneal Epithelium and Endothelium Influences the Fates of Orthotopic and Heterotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1908 - 1915. [Abstract] [Full Text] [PDF]

				J. Hori, T. F. Ng, M. Shatos, H. Klassen, J. W. Streilein, and M. J. Young Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts Stem Cells, July 1, 2003; 21(4): 405 - 416. [Abstract] [Full Text] [PDF]

				J. Hori and J. W. Streilein Survival in High-Risk Eyes of Epithelium-Deprived Orthotopic Corneal Allografts Reconstituted In Vitro with Syngeneic Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 658 - 664. [Abstract] [Full Text] [PDF]

				T. F. Ng, H. Osawa, J. Hori, M. J. Young, and J. W. Streilein Allogeneic Neonatal Neuronal Retina Grafts Display Partial Immune Privilege in the Subcapsular Space of the Kidney J. Immunol., November 15, 2002; 169(10): 5601 - 5606. [Abstract] [Full Text] [PDF]

				K.-H. Sonoda, M. Taniguchi, and J. Stein-Streilein Long-Term Survival of Corneal Allografts Is Dependent on Intact CD1d-Reactive NKT Cells J. Immunol., February 15, 2002; 168(4): 2028 - 2034. [Abstract] [Full Text] [PDF]

				J. Hori and J. W. Streilein Dynamics of Donor Cell Persistence and Recipient Cell Replacement in Orthotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1820 - 1828. [Abstract] [Full Text] [PDF]

				J. Hori and J. W. Streilein Role of Recipient Epithelium in Promoting Survival of Orthotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 720 - 726. [Abstract] [Full Text]